Divis Laboratories Ltd.
BSE: 532488 | Sector: Health care |
NSE: DIVISLAB | ISIN Code: INE361B01024 |
BSE 14:56 | 30 Jan | 3365.20 |
-20.35 (-0.60%) |
OPEN
3388.60 |
HIGH
3404.00 |
LOW
3353.00 |
NSE 14:44 | 30 Jan | 3367.95 |
-19.50 (-0.58%) |
OPEN
3399.95 |
HIGH
3405.05 |
LOW
3352.45 |
OPEN | 3388.60 |
PREVIOUS CLOSE | 3385.55 |
VOLUME | 2769 |
52-Week high | 4640.95 |
52-Week low | 3197.00 |
P/E | 30.09 |
Mkt Cap.(Rs cr) | 89,329 |
Buy Price | 3365.00 |
Buy Qty | 1.00 |
Sell Price | 3367.05 |
Sell Qty | 1.00 |
About Divis Laboratories Ltd.
Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the world manufacturing Active Pharmaceutical Ingredients (APIs) Intermediates and Nutraceuticals. The Company is one of the world's largest API companies with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (API's) Intermediates and N...> More
Divis Laboratories Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | ( cr) | 89,329 | |
EPS - TTM | () | [*S] | 111.83 |
P/E Ratio | (X) | [*S] | 30.09 |
Face Value | () | 2 | |
Latest Dividend | (%) | 1500.00 | |
Latest Dividend Date | 11 Aug 2022 | ||
Dividend Yield | (%) | 0.89 | |
Book Value / Share | () | [*S] | 454.85 |
P/B Ratio | () | [*S] | 7.40 |
News
Announcement
-
Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Fin
-
Divi's Laboratories Limited - Certificate under SEBI (Depositories and Participants) Regulations, 20
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Divis Laboratories Ltd - Financial Results
Particulars ( cr) | Sep 2022 | Sep 2021 | % Chg |
Net Sales | 1854.54 | 1987.51 | -6.69 |
Other Income | 80.08 | 19.11 | 319.05 |
Total Income | 1934.62 | 2006.62 | -3.59 |
Total Expenses | 1233.5 | 1169.44 | 5.48 |
Operating Profit | 701.12 | 837.18 | -16.25 |
Net Profit | 493.6 | 606.46 | -18.61 |
Equity Capital | 53.09 | 53.09 | - |
Divis Laboratories Ltd - Peer Group
Company | Price() | Chg (%) | Mkt Cap ( CR) |
Sun Pharma.Inds. | 1046.75 | 0.30 | 251146.72 |
Divi's Lab. | 3365.20 | -0.60 | 89329.23 |
Cipla | 1033.40 | -1.30 | 83410.88 |
Dr Reddy's Labs | 4308.90 | -0.22 | 71751.80 |
Torrent Pharma. | 1544.10 | 0.41 | 52258.52 |
Divis Laboratories Ltd - SHAREHOLDING PATTERN
|
|
Divis Laboratories Ltd - Research Reports
Divis Laboratories Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -0.61% | -0.52% | -2.76% | -3.09% |
1 Month | -1.39% | -1.33% | -2.60% | -3.02% |
3 Month | -5.13% | -5.06% | -1.17% | -1.29% |
6 Month | -12.12% | -12.10% | 2.93% | 2.33% |
1 Year | -14.63% | -14.53% | 3.60% | 2.67% |
3 Year | 71.75% | 71.91% | 44.84% | 45.88% |
Divis Laboratories Ltd - STOCK STRENGTH
Today's Low/High | 3353.00 | 3404.00 | |
Week Low/High | 3303.50 | 3414.00 | |
Month Low/High | 3282.00 | 3520.00 | |
YEAR Low/High | 3197.00 | 4641.00 | |
All TIME Low/High | 7.70 | 5425.00 |
Quick Links for Divis Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices